LoginSignup
Inmode logo

Inmode

Stock
Stock
ISIN: IL0011595993
Ticker: INMD
IL0011595993
INMD

Price

Price

Frequently asked questions

What is Inmode's market capitalization?

The market capitalization of Inmode is $1.41B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is Inmode's Price-to-Earnings (P/E) ratio?

The Price-to-Earnings (P/E) ratio (TTM) for Inmode is 10.01. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.

What is the Earnings Per Share (EPS) for Inmode?

Inmode's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $1.846. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Inmode's stock?

Currently, 6 analysts cover Inmode's stock, with a consensus target price of $25.60. Analyst ratings provide insights into the stock's expected performance.

What is Inmode's revenue over the trailing twelve months?

Over the trailing twelve months, Inmode reported a revenue of $423.75M.

What is the EBITDA for Inmode?

Inmode's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $136.51M. EBITDA measures the company's overall financial performance.

What is the free cash flow of Inmode?

Inmode has a free cash flow of $161.04M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

What is the 5-year beta of Inmode's stock?

The 5-year beta for Inmode is 2.07. A beta value indicates the stock's volatility relative to the market; a beta greater than 1 means higher volatility.

How many employees does Inmode have, and what sector and industry does it belong to?

Inmode employs approximately 581 people. It operates in the Health Care sector, specifically within the Medical Equipment & Supplies industry.

What is the free float of Inmode's shares?

The free float of Inmode is 68.05M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap

 $1.41B

5Y beta

 2.07

EPS (TTM)

 $1.846

Free Float

 68.05M

P/E ratio (TTM)

 10.01

Revenue (TTM)

 $423.75M

EBITDA (TTM)

 $136.51M

Free Cashflow (TTM)

 $161.04M

Pricing

1D span
$18.27$18.64
52W span
$14.87$26.80

Analyst Ratings

The price target is $25.60 and the stock is covered by 6 analysts.

Buy

2

Hold

4

Sell

0

Information

Inmode Ltd is an Israel-based global provider of energy-based, minimally-invasive surgical medical treatment solutions. Company's products and solutions are primarily designed to address three energy-based treatment categories comprised of: face and body contouring; medical aesthetics; and women’s health. The Company have developed and commercialized products utilizing medically-accepted RF energy technology, which can penetrate deep into the subdermal fat, allowing adipose tissue remodeling. It's RF energy-based proprietary technologies - Radio Frequency Assisted Lipolysis (RFAL), Deep Subdermal Fractional RF, Simultaneous Fat Destruction and Skin Tightening and Deep Heating Collagen Remodeling for skin and human natural openings- represent a paradigm shift in the minimally-invasive aesthetic solutions market. These technologies are used by physicians to remodel subdermal adipose, or fatty tissue in a variety of procedures.

581

Medical Equipment & Supplies

Health Care

Identifier

ISIN

IL0011595993

Primary Ticker

INMD

Knockouts

Join the conversation
Sign upLogin